A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery
Conditions
- Osteoarthritis
- Pain Assessment
- Arthralgia
Interventions
- DRUG: CG5503 IR; tapentadol
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Collaborators